 |
|
|
| |
ROBUST HEPATITIS B SURFACE ANTIGEN REDUCTION BY HT-101 IN CHRONIC
HEPATITIS B PATIENTS: RESULTS FROM A PHASE Ι B STUDY
|
| |
| |
AASLD 2024 Nov 15-19 San Diego
D. Wang1, SZ. Zhang1, YQ. Ma1, LJ. Ding1, ZP. Zhang1, H. Ma2, JD. Jia2,
1Suzhou Hepa Thera Biopharmaceutical Co.Ltd., Shanghai, China, 2 Beijing Friendship Hospital, Capital Medical University, Beijing, China
|
| |
|
|
|
|
|
